Senior VP, Clinical Research and Medical Affairs

Dr. Selmer graduated from the University of Copenhagen, Denmark summa cum laude. After residency training he worked two years with Internal Medicine followed by three years with Infectious Medicine at the University Hospital of Hvidovre, Denmark. In 1983 he joined Novo later Novo Nordisk A/S where he initially worked as senior scientist. Within a few years he was promoted Vice President. During his career at Novo Nordisk he had organizational responsibilities for most activities within the research organization including the formulation and implementation of Novo Nordisk's research strategies within new business areas. He was a permanent member of the strategy groups for Novo Nordisk core areas: diabetes, growth hormone, and new biopharmaceuticals. In 1995 Dr. Selmer was made responsible for the development and progression of the non-insulin diabetes portfolio and was ultimately also given the responsibility for the scientific management of all these projects until clinical proof of concept. Dr. Selmer's research interests have been within the areas of diabetes, appetite regulation and haemostasis.